Holen Sie sich die Stockscreener-App
1.55
7.19%
-0.12
Handel nachbörslich:
1.54
-0.01
-0.65%
Schlusskurs vom Vortag:
$1.67
Offen:
$1.66
24-Stunden-Volumen:
76,192
Relative Volume:
1.27
Marktkapitalisierung:
$7.06M
Einnahmen:
$32.96M
Nettoeinkommen (Verlust:
$-4.23M
KGV:
-0.00998
EPS:
-155.3294
Netto-Cashflow:
$-14.00M
1W Leistung:
+1.31%
1M Leistung:
+8.39%
6M Leistung:
+12.32%
1J Leistung:
-49.35%
1-Tages-Spanne:
$1.50
$1.6607
1-Wochen-Bereich:
$1.50
$1.76
52-Wochen-Spanne:
$1.1693
$3.90
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Firmenname
Sunshine Biopharma Inc
Sektor
Telefon
954-330-0684
Adresse
333 LAS OLAS WAY, FORT LAUDERDALE
Vergleichen Sie SBFM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.55 | 7.61M | 32.96M | -4.23M | -14.00M | -155.33 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Sunshine Biopharma Inc Aktie (SBFM) Neueste Nachrichten
Combining price and volume data for Sunshine Biopharma Inc.2025 Volatility Report & Weekly High Momentum Picks - newser.com
What technical models suggest about Sunshine Biopharma Inc.’s comebackPortfolio Risk Report & Risk Controlled Swing Trade Alerts - newser.com
Price momentum metrics for Sunshine Biopharma Inc. explainedLayoff News & Expert Approved Momentum Trade Ideas - newser.com
Has Sunshine Biopharma Inc. Equity Warrant found a price floorForecast Cut & AI Forecast Swing Trade Picks - newser.com
Sector ETF performance correlation with Sunshine Biopharma Inc.Market Trend Review & Free Reliable Trade Execution Plans - newser.com
How to forecast Sunshine Biopharma Inc. trends using time seriesMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Sunshine Biopharma develops new oral coronavirus inhibitors By Investing.com - Investing.com Canada
Using AI based signals to follow Sunshine Biopharma Inc. Equity Warrant2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com
Sunshine Biopharma develops new oral coronavirus inhibitors - Investing.com India
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections - ACCESS Newswire
Applying Wyckoff theory to Sunshine Biopharma Inc. Equity Warrant stockMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com
What indicators show strength in Sunshine Biopharma Inc. Equity Warrant2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
Key resistance and support levels for Sunshine Biopharma Inc.Global Markets & Free Reliable Trade Execution Plans - newser.com
Sunshine Biopharma Inc. Equity Warrant stock volume spike explainedJuly 2025 Setups & Fast Entry High Yield Tips - newser.com
Sunshine Biopharma’s (SBFM) Sell (E+) Rating Reaffirmed at Weiss Ratings - Defense World
Real time breakdown of Sunshine Biopharma Inc. Equity Warrant stock performanceDollar Strength & Community Supported Trade Ideas - newser.com
Aegis Capital Reiterates Sunshine Biopharma (SBFM) Buy Recommendation - Nasdaq
Sunshine Biopharma (SBFM) Receives Reiterated 'Buy' Rating from Aegis Capital | SBFM Stock News - GuruFocus
What drives Sunshine Biopharma Inc Equity Warrant stock priceCurrency Fluctuation Impact & Double Digit Capital Growth - earlytimes.in
Institutional scanner results for Sunshine Biopharma Inc.July 2025 Price Swings & Expert Verified Movement Alerts - newser.com
Can technical indicators confirm Sunshine Biopharma Inc.’s reversal - newser.com
Market reaction to Sunshine Biopharma Inc. Equity Warrant’s recent newsMarket Volume Report & High Accuracy Trade Signal Alerts - newser.com
Is Sunshine Biopharma Inc. showing signs of accumulation2025 Market Overview & Community Consensus Stock Picks - newser.com
How sustainable is Sunshine Biopharma Inc. stock dividend payoutJuly 2025 Chart Watch & Advanced Technical Analysis Signals - newser.com
Does Sunshine Biopharma Inc. Equity Warrant qualify in momentum factor screeningWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Sunshine Biopharma Inc Equity Warrant Stock Analysis and ForecastAutomated Trading Signals & Capital Efficiency Improvement - earlytimes.in
Will Sunshine Biopharma Inc. Equity Warrant stock outperform value stocksWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Best data tools to analyze Sunshine Biopharma Inc. stockJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
What’s next for Sunshine Biopharma Inc. Equity Warrant stock priceEarnings Miss & Smart Allocation Stock Reports - newser.com
Is Sunshine Biopharma Inc. Equity Warrant stock supported by innovation pipelineJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Can Sunshine Biopharma Inc. Equity Warrant hit a new high this month2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
Multi factor analysis applied to Sunshine Biopharma Inc.July 2025 Sector Moves & Low Risk High Win Rate Stock Picks - newser.com
Sunshine Biopharma (NASDAQ:SBFM) Shares Down 1.9% – Here’s What Happened - Defense World
Sunshine Biopharma Inc Stock Analysis and ForecastStock Screening Results & Calculate Profit Targets With AI Accuracy - earlytimes.in
What analysts say about Sunshine Biopharma Inc stockInterest Rate Changes & Identify Breakout Stocks - earlytimes.in
Using portfolio simulators with Sunshine Biopharma Inc. includedRate Cut & Daily Risk Controlled Trade Plans - newser.com
Sunshine Biopharma appoints M&K CPAS as new independent auditor By Investing.com - Investing.com South Africa
Finanzdaten der Sunshine Biopharma Inc-Aktie (SBFM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):